PROV SACRED HEART MEDICAL CENTER
The Sunshine Act requires manufacturers to report payments to teaching hospitals as institutions, separately from payments to individual physicians. These figures are money reported to the hospital itself — most of it research funding and grants, not compensation to any named doctor.
- Total reported
- $6.3M
- Transactions
- 1,370
- Companies
- 40
- Average per transaction
- $4,577
Who reported the payments
| Eli Lilly | $840,807 |
| Jazz Pharmaceuticals Inc. | $704,399 |
| Janssen Research & Development, LLC | $681,276 |
| Vertex | $535,724 |
| Stryker | $284,782 |
| Travere Therapeutics, Inc. | $257,579 |
| Gilead | $219,714 |
| Bayer | $208,359 |
| Endotronix, Inc. | $193,537 |
| Livanova USA, Inc. | $178,561 |
| GSK | $154,747 |
| Biogen | $150,675 |
| Merck | $150,376 |
| Acutus Medical, Inc. | $144,000 |
| Boehringer Ingelheim | $129,258 |
| Pfizer | $119,031 |
| Fujifilm Healthcare Americas Corporation | $105,606 |
| Medtronic | $98,803 |
| American Regent | $98,413 |
| E.r. Squibb & Sons, L.L.C. | $93,169 |
| Amgen | $91,499 |
| Abbott | $84,042 |
| Novo Nordisk AS | $71,728 |
| Novo Nordisk | $62,490 |
| United Therapeutics Corporation | $47,465 |
| Atricure, Inc. | $45,712 |
| Astrazeneca UK Limited | $43,657 |
| EKOS Corporation | $38,475 |
| Concordia Laboratories Inc. | $37,882 |
| AstraZeneca | $37,309 |
| Endologix LLC | $36,514 |
| Boston Scientific | $34,362 |
| Edwards Lifesciences | $30,513 |
| Daiichi Sankyo Inc. | $28,385 |
| Novartis | $25,009 |
| CSL Behring | $24,412 |
| Actelion Pharmaceuticals, Ltd | $18,701 |
| Pacira Pharmaceuticals Incorporated | $15,834 |
| EMD Serono, Inc. | $12,405 |
| Boehringer Ingelheim Pharma GmbH & Co.kg | $12,387 |